Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.

por Xerri, L., Bouabdallah, R., Devilard, E., Hassoun, J., Stoppa, A. M., Birg, F.
Publicado 1998

NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival.

por Xerri, L., Grob, J. J., Battyani, Z., Gouvernet, J., Hassoun, J., Bonerandi, J. J.
Publicado 1994

Molecular characterization of breast cell lines: a tool for breast cancer studies

por Charafe-Jauffret, E, Ginestier, C, Monville, F, Adélaïde, J, Finetti, P, Bertucci, F, Xerri, L, Jacquemier, J, Birnbaum, D
Publicado 2005

EZH2 alterations in follicular lymphoma: biological and clinical correlations

por Huet, S, Xerri, L, Tesson, B, Mareschal, S, Taix, S, Mescam-Mancini, L, Sohier, E, Carrère, M, Lazarovici, J, Casasnovas, O, Tonon, L, Boyault, S, Hayette, S, Haioun, C, Fabiani, B, Viari, A, Jardin, F, Salles, G
Publicado 2017

P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE II...

por Cartron, G., Bachy, E., Tilly, H., Daguindau, N., Pica, G.-M., Bijou, F., Mounier, C., Clavert, A. M., Damaj, G. L., Slama, B., Casasnovas, O., Houot, R., Bouabdallah, K., Sibon, D., Fitoussi, O., Morineau, N., Herbaux, C., Gastinne, T., Fornecker, L.-M., Haioun, C., Launay, V., Araujo, C., Benbrahim, O., Sanhes, L., Gressin, R., Gonzalez, H., Morschhauser, F., Xerri, L., Tarte, K., Pranger, D.
Publicado 2022